Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers

PURPOSE: Boosting dominant intra-prostatic lesions (DILs) has the potential to increase the therapeutic ratio in prostate cancer radiotherapy. In this study, employing 5-fraction stereotactic ablative radiotherapy (SABR) volumetric modulated arc therapy (VMAT) to deliver 40 Gy to the prostate clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Osman, Sarah O. S., Fairmichael, Ciaran, Whitten, Glenn, Lundy, Gavin S., Wesselman, Rachel, Wilson, Melissa LaBonte, Hounsell, Alan R., Prise, Kevin M., Irvine, Denise, McGarry, Conor K., Jain, Suneil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862253/
https://www.ncbi.nlm.nih.gov/pubmed/35193630
http://dx.doi.org/10.1186/s13014-022-02003-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862253/
https://www.ncbi.nlm.nih.gov/pubmed/35193630
http://dx.doi.org/10.1186/s13014-022-02003-8

Ejemplares similares